RELMADA THERAPEUTICS, INC. Gross Profit
RELMADA THERAPEUTICS, INC. (RLMD) reported Gross Profit of -$3 for the 3-month period ending 2014-02-28, per its 10-Q filed 2014-04-15.
Discontinued › Income Statement
us-gaap:GrossProfit · last filed 2014-04-15
- RELMADA THERAPEUTICS, INC. gross profit for the quarter ending 2014-02-28 was -$3.00, a 100.62% decline year-over-year.
- RELMADA THERAPEUTICS, INC. gross profit for the quarter ending 2013-11-30 was $164.00, a 45.15% decline year-over-year.
- RELMADA THERAPEUTICS, INC. gross profit for the quarter ending 2013-08-31 was $0.00, a 100.00% decline year-over-year.
- RELMADA THERAPEUTICS, INC. gross profit for the quarter ending 2013-05-31 was $312.00, a 188.89% increase year-over-year.
- RELMADA THERAPEUTICS, INC. gross profit for fiscal 2013 was $1.09K, a 48.97% decline from fiscal 2012.
- RELMADA THERAPEUTICS, INC. gross profit for fiscal 2012 was $2.14K.
| Period end | Gross Profit 3 month | Gross Profit 6 month | Gross Profit 9 month | Gross Profit 12 month | Gross Profit 21 month | Gross Profit 24 month | Gross Profit 27 month | Gross Profit 30 month | Gross Profit 33 month |
|---|---|---|---|---|---|---|---|---|---|
| 2014-02-28 | -$3.00 10-Q · filed 2014-04-15 | $161.00 10-Q · filed 2014-04-15 | $161.00 derived: sum of 3 quarters · filed 2014-04-15 | $473.00 derived: sum of 4 quarters · filed 2014-04-15 | $3.40K 10-Q · filed 2014-04-15 | ||||
| 2013-11-30 | $164.00 10-Q · filed 2014-01-13 | $164.00 derived: sum of 2 quarters · filed 2014-01-13 | $476.00 derived: sum of 3 quarters · filed 2014-01-13 | $958.00 derived: sum of 4 quarters · filed 2014-04-15 | $3.40K 10-Q · filed 2014-01-13 | ||||
| 2013-08-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-16 | $312.00 derived: sum of 2 quarters · filed 2013-12-16 | $794.00 derived: sum of 3 quarters · filed 2014-04-15 | $1.09K 10-K · filed 2013-12-16 | $3.23K 10-K · filed 2013-12-16 | ||||
| 2013-05-31 | $312.00 10-Q · filed 2013-07-12 | $794.00 derived: sum of 2 quarters · filed 2014-04-15 | $1.09K 10-Q · filed 2013-07-12 | $1.61K derived: sum of 4 quarters · filed 2014-04-15 | $3.23K 10-Q · filed 2013-07-12 | ||||
| 2013-02-28 | $482.00 10-Q · filed 2014-04-15 | $781.00 10-Q · filed 2014-04-15 | $1.30K derived: sum of 3 quarters · filed 2014-04-15 | $1.41K derived: sum of 4 quarters · filed 2014-04-15 | $2.92K 10-Q · filed 2013-05-03 | ||||
| 2012-11-30 | $299.00 10-Q · filed 2014-01-13 | $816.00 derived: sum of 2 quarters · filed 2014-01-13 | $924.00 derived: sum of 3 quarters · filed 2014-01-13 | $2.44K derived: sum of 4 quarters · filed 2014-01-13 | |||||
| 2012-08-31 | $517.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-16 | $625.00 derived: sum of 2 quarters · filed 2013-12-16 | $2.14K derived: sum of 3 quarters · filed 2013-12-16 | $2.14K 10-K · filed 2013-12-16 | |||||
| 2012-05-31 | $108.00 10-Q · filed 2013-07-12 | $1.63K derived: sum of 2 quarters · filed 2013-07-12 | $1.63K 10-Q · filed 2013-07-12 | ||||||
| 2012-02-29 | $1.52K 10-Q · filed 2013-05-03 | $1.52K 10-Q · filed 2013-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |